In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix Pro, the Johnson & Johnson Vision Tecnis Odyssey and the Bausch + Lomb enVista Envy.
These IOL designs have similarities: They all split the incoming light to provide a large degree of spectacle independence, and they all provide a wide range of uncorrected vision from near to intermediate to far. All these IOLs can make some of our cataract patients very happy, but they can also disappoint other patients.
When we consider (Read more...)